[Myasthenia gravis. Longitudinal course and therapeutic aspects].
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors; D003366:Cosyntropin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000628:therapy; D011239:Prednisolone / Q000627:therapeutic use; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D012075:Remission, Spontaneous; D013934:Thymectomy
D002800:Cholinesterase Inhibitors; D004791:Enzyme Inhibitors; D003366:Cosyntropin; D011239:Prednisolone; D011729:Pyridostigmine Bromide; D001379:Azathioprine
Myasthenia gravis Längsschnittverläufe und therapeutische Aspekte.